A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

NCT05783921 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Squamous Cell Carcinoma of the Head and Neck
Metastatic Squamous Cell Carcinoma

Interventions

DRUG: TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
DRUG: Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.